Clinical Trial Update: Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and efficacy of KW-136 with Sofosbuvir for chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• KW-136
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Kawin Technology Share-holding Co., Ltd. | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED